A new treatment option for ulcerative colitis
- PMID: 17597673
A new treatment option for ulcerative colitis
Comment on
-
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.Aliment Pharmacol Ther. 2006 Oct 1;24(7):1087-97. doi: 10.1111/j.1365-2036.2006.03082.x. Aliment Pharmacol Ther. 2006. PMID: 16984503 Clinical Trial.
Similar articles
-
Medical treatment of ulcerative colitis.J Assoc Physicians India. 2007 Sep;55:635-40. J Assoc Physicians India. 2007. PMID: 18051737 Review.
-
Therapy of ulcerative colitis: state of the art.Curr Opin Gastroenterol. 2008 Jul;24(4):469-74. doi: 10.1097/MOG.0b013e3282ff0dd5. Curr Opin Gastroenterol. 2008. PMID: 18622161 Review.
-
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.Aliment Pharmacol Ther. 2008 Mar;27 Suppl 1:15-21. doi: 10.1111/j.1365-2036.2008.03606.x. Aliment Pharmacol Ther. 2008. PMID: 18307645 Review.
-
Review article: the management of steroid dependency in ulcerative colitis.Aliment Pharmacol Ther. 2007 Sep 15;26(6):779-94. doi: 10.1111/j.1365-2036.2007.03334.x. Aliment Pharmacol Ther. 2007. PMID: 17767462 Review.
-
A review of infliximab use in ulcerative colitis.Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Clin Ther. 2008. PMID: 18343261 Review.